Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year earnings per share growth rate
Latest
168.75%
↑ 823% above average
Average (9y)
18.27%
Historical baseline
Range
High:168.75%
Low:-209.09%
CAGR
+16.1%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 168.75% |
| 2023 | 57.65% |
| 2022 | -209.09% |
| 2021 | 38.89% |
| 2020 | 55.00% |
| 2019 | 9.09% |
| 2018 | 28.69% |
| 2017 | 15.83% |
| 2016 | -25.95% |
| 2015 | 43.88% |